Ramoplanin: a lipoglycodepsipeptide antibiotic (Q34405651)

2 August 2017

1 reference

title

Ramoplanin: a lipoglycodepsipeptide antibiotic (English)

1 reference

2 August 2017

Debra K Farver

1

1 reference

2 August 2017

Dennis D Hedge

series ordinal

2

1 reference

2 August 2017

Steven C Lee

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

22 March 2005

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

39

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

863-868

1 reference

Resistance patterns among nosocomial pathogens: trends over the past few years

2 August 2017

cites work

1 reference

Recurrent Clostridium difficile colitis. Tackling a tenacious nosocomial infection

21 January 2018

1 reference

Chemistry and biology of the ramoplanin family of peptide antibiotics

21 January 2018

1 reference

Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies

21 January 2018

1 reference

Total synthesis of the ramoplanin A2 and ramoplanose aglycon

21 January 2018

1 reference

Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II.

21 January 2018

1 reference

Bactericidal activity of ramoplanin against antibiotic-resistant enterococci

21 January 2018

1 reference

In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci

21 January 2018

1 reference

Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

21 January 2018

1 reference

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria

21 January 2018

1 reference

In vitro activity of A-16686, a new glycopeptide.

21 January 2018

1 reference

Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci

21 January 2018

1 reference

In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms

21 January 2018

1 reference

Linezolid for the treatment of resistant gram-positive cocci

21 January 2018

1 reference

Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.

21 January 2018

1 reference

In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.

21 January 2018

1 reference

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

21 January 2018

1 reference

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

Enterococcus, an emerging pathogen

21 January 2018

1 reference

Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin

21 January 2018

1 reference

Clinical impact of vancomycin-resistant enterococci

21 January 2018

1 reference

Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients

21 January 2018

1 reference

Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice

21 January 2018

1 reference

A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.309

Identifiers

DOI

10.1345/APH.1E397

1 reference

2 August 2017

1 reference